Centre for In Vivo Modelling
The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to address fundamental questions in cancer biology, with the ultimate aim of identifying curative treatments. We also serve as a collaborative hub across the ICR and The Royal Marsden, providing cutting-edge expertise in advanced mouse genetics and humanised in vivo models of cancer.
Professor Kamil R Kranc, Chair of Haemato-Oncology, serves as the Centre's Director, while Fabiana Muzzonigro is the Centre Administrator.
How we conduct research at this centre
Solid tumours and blood cancers are highly complex ecosystems, with many composed of varying cell types including rare cancer stem cells at the apex of a hierarchical organisation, more differentiated malignant progeny, and a dynamic microenvironment that nurtures tumour growth and survival. At our Centre, we seek to elucidate the fundamental principles that govern this malignant ecosystem. We employ advanced mouse genetics (including barcoding and lineage tracing) and PDX models to dissect how tumour cells function, evolve under selective pressures, evade therapy, and engage with their microenvironment to sustain disease progression. By decoding these intricate cellular and molecular interactions, we aim to identify transformative therapeutic strategies capable of eradicating cancer at its origin - achieving durable remission while preserving normal tissue integrity.
A particular strength of our Centre lies in the generation and application of in vivo models, which are essential for uncovering novel aspects of cancer biology and evaluating emerging therapies. We work in close collaboration with ICR researchers and clinicians at The Royal Marsden to develop patient-derived xenograft (PDX) models of leukaemias and solid tumours by transplanting human cancer tissue into immunocompromised mice. In parallel, we generate and utilise genetically engineered mouse models (GEMMs) to interrogate cancer biology in a physiologically relevant context. By leveraging these sophisticated in vivo systems, the Centre aims to:
- Uncover new facets of cancer biology in a complex in vivo ecosystem
- Discover and validate novel therapeutic targets allowing for elimination of cancer stem cells and their malignant progeny in blood cancers and solid tumours
- Collaborate closely with drug discovery teams at the ICR to develop inhibitors of these targets
- Evaluate new anti-cancer drugs in pre-clinical in vivo models, paving the way for clinical trials.
In addition to our academic focus, CIVM serves as a collaborative hub across the ICR and The Royal Marsden, providing the ICR community with cutting-edge expertise in advanced mouse genetics and humanised mouse models of cancer.
Members of this Centre
Professor Kamil Kranc
Director of the Centre of In Vivo Modelling: Group Leader
Haemato-Oncology Group
Professor Kristian Helin
Group Leader
Epigenetics and Cancer
Professor Axel Behrens
Group Leader
Cancer Stem Cell
Professor Cathrin Brisken
Group Leader
Endocrine Control Mechanisms
Professor Louis Chesler
Clinical Senior Lecturer/Group Leader
Paediatric Solid Tumour Biology and Therapeutics
Dr Amanda Swain
Group Leader
Development and Cancer
Dr Marco Bezzi
Group Leader
Tumour Functional Heterogeneity
Professor Chris Jones
Head of Division
Glioma
Dr Olivia Rossanese
Director of the Centre for Cancer Drug Discovery & Head of Division
Tumour Microenvironment and Pharmacology Target Evaluation and Molecular Therapeutics
In Vivo Modelling core
We provide cutting-edge expertise in advanced mouse genetics and humanized mouse models of cancer.CIVM Service Core
Dr Francisca Nunes de Almeida
Staff Scientist
Dr Chenxin Liu
Technician
Dr Kallayanee Chawengsaksophak
Senior Staff Scientist
Other staff:
Email: [email protected]
Driving discovery through collaboration
At CIVM, our collaborative spirit drives our mission to advance cancer cures. We actively partner with basic science, translational, and clinical research groups across the ICR and The Royal Marsden. Our collaborations also extend beyond, working closely with distinguished academic teams at the Universities of Oxford, Cambridge, Edinburgh, Cardiff, London, Glasgow, and the Francis Crick Institute.
News from the Centre
We are recruiting a Group Leader in In Vivo Cancer Modelling. We welcome applications at both the Career Development Faculty and Career Faculty levels. Competitive start up package is available. For further particulars please contact [email protected].